STOCK TITAN

Enlivex (ENLV) director discloses major share and option stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Enlivex Ltd. director Shai A. Novik filed an initial Form 3 reporting his beneficial ownership. He holds 6,974,017 Ordinary Shares, par value NIS 0.40 per share, directly. The filing also lists multiple option awards to buy additional ordinary shares at exercise prices between 2.6900 and 12.2300, with expirations from 2030-05-03 to 2033-12-31. This Form 3 records existing holdings and does not show new purchases or sales.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
NOVIK SHAI A

(Last)(First)(Middle)
14 EINSTEIN STREET

(Street)
NESS ZIONA7403618

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Enlivex Ltd. [ ENLV ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares, par value NIS 0.40 per share6,974,017D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Option (right to buy)12/12/202112/31/2033Ordinary Shares, par value NIS 0.40 per share145,237$6.22D
Option (right to buy)05/03/202305/03/2030Ordinary Shares, par value NIS 0.40 per share250,000$3.66D
Option (right to buy)05/28/202405/28/2031Ordinary Shares, par value NIS 0.40 per share250,000$12.23D
Option (right to buy)11/24/202511/17/2032Ordinary Shares, par value NIS 0.40 per share115,500$5.34D
Option (right to buy)11/17/202511/17/2032Ordinary Shares, par value NIS 0.40 per share250,000$5.34D
Option (right to buy)06/01/201912/31/2033Ordinary Shares, par value NIS 0.40 per share132,979$2.69D
Explanation of Responses:
Remarks:
See Exhibit 24.1 - Power of Attorney
/s/ Shachar Shlosberger, Attorney-in-Fact03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Enlivex (ENLV) Form 3 filing by Shai A. Novik show?

The Form 3 shows director Shai A. Novik’s initial reported holdings in Enlivex Ltd. It discloses 6,974,017 ordinary shares held directly, plus several option awards to acquire additional ordinary shares at preset exercise prices and future expiration dates, establishing his baseline beneficial ownership position.

How many Enlivex ordinary shares does Shai A. Novik report owning on Form 3?

Shai A. Novik reports direct ownership of 6,974,017 Ordinary Shares, par value NIS 0.40 per share. This figure represents his stated beneficial ownership of Enlivex’s ordinary equity, separate from any options that could convert into additional shares if exercised in the future.

What stock options are reported for Shai A. Novik in the Enlivex Form 3?

The filing lists several option grants to buy ordinary shares, including blocks over 145,237 shares at an exercise price of 6.2200 and 250,000 shares at 3.6600. Additional grants carry exercise prices up to 12.2300, with expirations extending through dates such as 2033-12-31.

Does the Enlivex (ENLV) Form 3 indicate any recent insider buying or selling?

The Form 3 does not show recent buying or selling activity. All entries are coded as holdings with unknown transaction codes, meaning the document serves to disclose existing share and option positions rather than report new market transactions or changes in ownership direction.

Why is Shai A. Novik’s Enlivex Form 3 important for investors?

This Form 3 establishes Shai A. Novik’s baseline ownership as a director of Enlivex Ltd. It details his 6,974,017 ordinary shares and multiple option positions, helping investors understand his equity exposure and long-term alignment with the company’s performance at the time of reporting.
Enlivex Ltd

NASDAQ:ENLV

View ENLV Stock Overview

ENLV Rankings

ENLV Latest News

ENLV Latest SEC Filings

ENLV Stock Data

259.67M
236.28M
Biotechnology
Healthcare
Link
Israel
Ness Ziona